Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
August 2014
|
| In: |
OncoTarget
Year: 2014, Volume: 5, Issue: 16, Pages: 6620-6632 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2268 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.2268
|
| Author Notes: | Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch |
| Item Description: | Gesehen am 04.03.2016 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2268 |